Forum LIVE: Targeting BTK in Rheumatology
2nd November 2022
- John Isaacs (Chair)
- Edward Vital: The Bruton’s Tyrosine Kinase pathway – an attractive target in autoimmune disease?
- David Isenberg: Targeting the BTK pathway in SLE
- Stanley Cohen: Targeting the BTK pathway in RA
Forum LIVE: The role of JAK inhibitors in the treatment algorithm
5th October 2022
- Professor Ernest Choy (Chair)
- Professor Chris Edwards: Use of JAKi as the first advanced therapy and post-biologic
- Professor Rieke Alten: Real world data on the use of JAKi (JAKPOT study)
ForumLIVE: The evolution of targeted therapies from biologics to small molecules
7th September 2022
- Professor Peter Taylor: Interpreting clinical study designs
- Professor Rieke Alten: Endpoints
- All: How well does real world experience meet clinical trial expectation
Forum LIVE: Rationale for Treatment Selections in Inflammatory Arthritis
6th July 2022
- Professor Janet Pope: Rheumatoid Arthritis
- Professor Philip Mease: Psoriatic Arthritis
- Professor Eric Ruderman: Axial Spondyloarthritis
Forum LIVE: Precision Medicine in Rheumatoid Arthritis
15th June 2022
- Dr Grace Wright (Chair)
- Professor Ernest Choy: Precision Medicine in Rheumatoid Arthritis
- Professor Jeffrey Curtis: Precision Medicine for Rheumatoid Arthritis Patients
Forum Live - Inhibiting Cytokine Signalling Pathways: Similarities and Differences
2nd May 2022
- Professors Peter Nash: JAK Selectivity
- Professor John Issac: Mechanisms of JAK inhibitors: the same or different?